Sun Yat-sen University Cancer Center — Guangdong

Public research footprint of Sun Yat-sen University Cancer Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Platinum-resistant Ovarian Cancer · Nasopharyngeal Carcinoma (NPC) · Limited-stage Small Cell Lung Cancer (LS-SCLC)

Recently updated registry entries

NCT07218341 — A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… (Recruiting)
NCT06095583 — Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation… (Recruiting)
NCT07604766 — An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sun Yat-sen University Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.